- Home
- KAZR vs LRMR Comparison
KAZR vs LRMR Comparison
Compare KAZR & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$2.10
HOLD
Current Price
$3.98
Company Overview
Basic Information| Metric | KAZR | LRMR |
|---|---|---|
| Founded | N/A | N/A |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Engineering & Construction | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 398.1M | 455.8M |
| IPO Year | 2025 | 2014 |
Fundamental Metrics
Financial Performance| Metric | KAZR | LRMR |
|---|---|---|
| Price | $2.10 | $3.98 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $16.50 |
| AVG Volume (30 Days) | 142.8K | ★ 1.7M |
| Earning Date | N/A | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1,816.14 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.60 | $2.72 |
| 52 Week High | $3.20 | $6.42 |
Technical Indicators
Market Signals| Indicator | KAZR | LRMR |
|---|---|---|
| Relative Strength Index (RSI) | 44.99 | 53.72 |
| Support Level | $1.60 | $3.87 |
| Resistance Level | $3.07 | $4.21 |
| Average True Range (ATR) | 0.33 | 0.22 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 44.78 | 52.76 |
Price Performance
Historical Comparison KAZR
LRMR
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.